Article
Epigenetic regulators as promising therapeutic targets in acute myeloid leukemia
27 Apr 2015
Abstract excerpt
Acute myeloid leukemia (AML), the most prevalent acute leukemia in adults, is an aggressive hematological malignancy arising in hematopoietic stem and progenitor cells. With the exception of a few specific AML subtypes, the mainstays of treatment have not significantly changed over the last 20 years, and are still based on standard cytotoxic chemotherapy. As a result, clinical outcome remains poor for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
